These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 36520610)
81. Neuropeptide VGF C-Terminal Peptide TLQP-62 Alleviates Lipopolysaccharide-Induced Memory Deficits and Anxiety-like and Depression-like Behaviors in Mice: The Role of BDNF/TrkB Signaling. Li C; Li M; Yu H; Shen X; Wang J; Sun X; Wang Q; Wang C ACS Chem Neurosci; 2017 Sep; 8(9):2005-2018. PubMed ID: 28594546 [TBL] [Abstract][Full Text] [Related]
82. Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze. Guimarães FS; de Aguiar JC; Mechoulam R; Breuer A Gen Pharmacol; 1994 Jan; 25(1):161-4. PubMed ID: 7913072 [TBL] [Abstract][Full Text] [Related]
83. Effect of prior foot shock stress and Δ Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834 [TBL] [Abstract][Full Text] [Related]
84. Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression. Domingos LB; Müller HK; da Silva NR; Filiou MD; Nielsen AL; Guimarães FS; Wegener G; Joca S Neuropharmacology; 2024 May; 248():109870. PubMed ID: 38401791 [TBL] [Abstract][Full Text] [Related]
85. The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice. Wang Q; Long Y; Hang A; Zan GY; Shu XH; Wang YJ; Liu JG Psychopharmacology (Berl); 2016 Jun; 233(12):2411-8. PubMed ID: 27113225 [TBL] [Abstract][Full Text] [Related]
86. The two synthetic cannabinoid compounds 4'-F-CBD and HU-910 efficiently restrain inflammatory responses of brain microglia and astrocytes. Dos Santos Pereira M; Maitan Santos B; Gimenez R; Guimarães FS; Raisman-Vozari R; Del Bel E; Michel PP Glia; 2024 Mar; 72(3):529-545. PubMed ID: 38013496 [TBL] [Abstract][Full Text] [Related]
87. Effect of a selective cyclooxygenase type 2 inhibitor celecoxib on depression associated with obesity in mice: an approach using behavioral tests. Kurhe Y; Mahesh R; Gupta D Neurochem Res; 2014 Jul; 39(7):1395-402. PubMed ID: 24816895 [TBL] [Abstract][Full Text] [Related]
88. Antidepressant- and anxiolytic-like activity of magnesium in mice. Poleszak E; Szewczyk B; Kedzierska E; Wlaź P; Pilc A; Nowak G Pharmacol Biochem Behav; 2004 May; 78(1):7-12. PubMed ID: 15159129 [TBL] [Abstract][Full Text] [Related]
89. Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model. Xu C; Chang T; Du Y; Yu C; Tan X; Li X Environ Toxicol Pharmacol; 2019 Aug; 70():103202. PubMed ID: 31173966 [TBL] [Abstract][Full Text] [Related]
90. Diuretic activity and neuropharmacological effects of an ethanol extract from Senna septemtrionalis (Viv.) H.S. Irwin & Barneby (Fabaceae). Alonso-Castro AJ; Alba-Betancourt C; Yáñez-Barrientos E; Luna-Rocha C; Páramo-Castillo AS; Aragón-Martínez OH; Zapata-Morales JR; Cruz-Jiménez G; Gasca-Martínez D; González-Ibarra AA; Álvarez-Camacho DA; Devezé-Álvarez MA J Ethnopharmacol; 2019 Jul; 239():111923. PubMed ID: 31034951 [TBL] [Abstract][Full Text] [Related]
91. Cannabidiol exhibits anxiolytic-like effects and antipsychotic-like effects in mice models. Shu G; He Y; Suo J; Wu C; Gong X; Xiang Y; Yang W; Cheng J; Wang Y; Chen W; Shen J Neurosci Lett; 2024 Mar; 826():137723. PubMed ID: 38467272 [TBL] [Abstract][Full Text] [Related]
92. Investigation of Cochlospermum religiosum leaves for antidepressant and anxiolytic activities and its synergistic effect with imipramine and fluoxetine. Bhatt S; Behl T; Sehgal A; Singh S; Sharma N; Chigurupati S; Ahmed AS; Gari SBV Environ Sci Pollut Res Int; 2022 Apr; 29(18):27172-27181. PubMed ID: 34981394 [TBL] [Abstract][Full Text] [Related]
93. Effects of Jiaotaiwan on depressive-like behavior in mice after lipopolysaccharide administration. Zhe Q; Sulei W; Weiwei T; Hongyan L; Jianwei W Metab Brain Dis; 2017 Apr; 32(2):415-426. PubMed ID: 27796565 [TBL] [Abstract][Full Text] [Related]
94. The Novel Pimavanserin Derivative ST-2300 with Histamine H Venkatachalam K; Zhong S; Dubiel M; Satała G; Sadek B; Stark H Biomolecules; 2022 May; 12(5):. PubMed ID: 35625611 [TBL] [Abstract][Full Text] [Related]
95. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Moreira FA; Aguiar DC; Guimarães FS Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1466-71. PubMed ID: 16876926 [TBL] [Abstract][Full Text] [Related]
97. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling. Fogaça MV; Campos AC; Coelho LD; Duman RS; Guimarães FS Neuropharmacology; 2018 Jun; 135():22-33. PubMed ID: 29510186 [TBL] [Abstract][Full Text] [Related]
98. Tert-butyl 4-((1-phenyl-1H-pyrazol-4-yl) methyl) piperazine-1-carboxylate (LQFM104)- New piperazine derivative with antianxiety and antidepressant-like effects: Putative role of serotonergic system. da Silva DM; Sanz G; Vaz BG; de Carvalho FS; Lião LM; de Oliveira DR; Moreira LKDS; Cardoso CS; de Brito AF; da Silva DPB; da Rocha FF; Santana IGC; Galdino PM; Costa EA; Menegatti R Biomed Pharmacother; 2018 Jul; 103():546-552. PubMed ID: 29677541 [TBL] [Abstract][Full Text] [Related]
99. Antidepressant and anxiolytic-like behavioral effects of erucamide, a bioactive fatty acid amide, involving the hypothalamus-pituitary-adrenal axis in mice. Li MM; Jiang ZE; Song LY; Quan ZS; Yu HL Neurosci Lett; 2017 Feb; 640():6-12. PubMed ID: 28082151 [TBL] [Abstract][Full Text] [Related]
100. Evaluation of the antianxiety and antidepressant activities of mosapride in Wistar albino rats. Krishna V; Bairy KL; Patil N; Sunny SV J Basic Clin Physiol Pharmacol; 2019 Jul; 30(4):. PubMed ID: 31318691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]